Skip to main content
No profile photo available

, MD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Oncology

Academic Office Information

U6069409@utah.edu

Board Certification

  • American Board of Internal Medicine (Internal Medicine)

Education History

Undergraduate Seth G.S Medical College & KEM Hospital
MBBS
Residency Allegheny Health Network
Resident
Fellowship University of Miami Leonard M. Miller School of Medicine
Fellow

Selected Publications

Journal Article

  1. Attah A, Huffman D, Asawa P, Edlukudige Keshava V, Shah D (2024). Asymptomatic COVID-19-Associated Acquired Hemophilia A and Disseminated Intravascular Coagulation From a Bypassing Agent. J Med Cases, 15(6), 106-109.
  2. Shah S, Asawa P, Abel S, Wegner RE (2023). Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer. J Gastrointest Cancer, 54(3), 829-836.
  3. Karna R, S Deliwala S, Ramgopal B, Asawa P, Mishra R, P Mohan B, Jayakrishnan T, Grover D, Kalra T, Bhalla J, Saraswati U, K Gangwani M, Dhawan M, G Adler D (2023). Gastrointestinal treatment-related adverse events of combined immune checkpoint inhibitors: a meta-analysis. Immunotherapy, 15(10), 773-786.
  4. Arora S, Asawa P, Kataria N, Hendriks LEL, Desai AP (2022). Management of Non-Small Cell Lung Cancer: Updates from the European Lung Cancer Congress 2022. Cancer Invest, 40(7), 577-589.
  5. Arora S, Asawa P, Ramakrishnan A, Bachier C, Majhail NS (2022). Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and Challenges. Hematol Oncol Stem Cell Ther, 15(3), 159-167.
  6. Abdeen M, Vusqa UT, Asawa P, Felton K, Rinchuse D, Khan C, Samhouri Y, Lister J (2022). Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia. Anticancer Drugs, 33(10), 1167-1170.
  7. Asawa P, Chahine Z, Vusqa U, Samhouri Y, Fazal S (2022). Invasive Aspergillosis of the Spleen in the setting of Ibrutinib use. J Oncol Pharm Pract, 28(7), 1654-1658.
  8. Asawa P, Bakalov V, Kancharla P, Abel S, Chahine Z, Monga DK, Kirichenko AV, Wegner RE (2022). The prognostic value of KRAS mutation in locally advanced rectal cancer. Int J Colorectal Dis, 37(5), 1199-1207.
  9. Vusqa UT, Asawa P, Fazal S, Samhouri Y (2022). Testicular Plasmacytoma Masking as Epididymo-orchitis in a Known Multiple Myeloma Patient. Cancer Diagn Progn, 2(5), 549-552.
  10. Vusqa UT, Chahine Z, Asawa P, Sadashiv S, Samhouri Y, Lister J (2022). Three Cases of Lenalidomide Therapy for Multiple Myeloma and Subsequent Development of Secondary B-ALL. J Oncol Pharm Pract, 28(5), 1214-1217.
  11. Asawa P, Vusqa U, Vashistha K, Ud Din MT, Karna R, Chen F, Dutton N, Samhouri Y, Fazal S (2022). Polyserositis as a Unique Presentation of Isolated Myeloid Sarcoma: A Case Report. Anticancer Res, 42(7), 3595-3599.
  12. Asawa P, Vusqa U, Khan C, Samhouri Y, Fazal S (2022). Intrathecal Chemotherapy as a Potential Treatment for Steroid-refractory Immune Effector Cell-associated Neurotoxicity Syndrome. Anticancer Res, 42(8), 3853-3856.